Home › Calculator › HLTRF Dividend Calculator 2026
HLTRF Dividend DRIP Calculator 2026
66.67% YieldHealthcareHLS Therapeutics Inc. · OTC
Price: $3.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When HLTRF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your HLTRF snowball 📈
$10,000 in HLTRF → $20.3K in 10 years · $0.98/month
About HLS Therapeutics Inc. (HLTRF) — Dividend Analysis 2026
HLS Therapeutics Inc. is a specialized pharmaceutical firm engaged in the acquisition and commercialization of medicinal products, with a primary focus on the central nervous system (CNS) and cardiovascular (CV) therapeutic areas. The company's activities extend across Canada, the United States, and international territories. Its core product lineup features Clozaril, an atypical antipsychotic medication prescribed for schizophrenia; Vascepa, composed of icosapent ethyl capsules; and PERSERIS, an injectable risperidone formulation also employed in the treatment of schizophrenia. Beyond pharmaceuticals, HLS Therapeutics offers MyCare psychiatry laboratory assays and MyCare Insite point-of-care diagnostic tests for monitoring drug levels. Additionally, the company possesses U.S. marketing rights for Absorica, a commercially available dermatology product, along with Canadian rights for Trinomia, a cardiovascular therapeutic. It also benefits from royalty streams derived from four other healthcare products. HLS Therapeutics Inc. was founded in 2018 and maintains its headquarters in Etobicoke, Canada.
Compare HLTRF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full HLTRF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open HLTRF position with:
🌍 HLTRF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold HLTRF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 66.67% | 63.87% | $6,667 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 56.67% | 53.87% | $5,667 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 53.34% | 50.54% | $5,334 / yr |
| 🇬🇧 UK ISA | 0% | 66.67% | 63.87% | $6,667 / yr |
| 🇬🇧 UK Taxable | 8.75% | 60.84% | 58.04% | $6,084 / yr |
| 🇨🇦 TFSA | 0% | 66.67% | 63.87% | $6,667 / yr |
| 🇨🇦 CA Taxable | 25% | 50.00% | 47.20% | $5,000 / yr |
| 🇦🇺 Super (pension) | 15% | 56.67% | 53.87% | $5,667 / yr |
| 🇦🇺 AU Taxable | 30% | 46.67% | 43.87% | $4,667 / yr |
| 🇩🇪 DE Taxable | 26.375% | 49.09% | 46.29% | $4,909 / yr |
| 🇫🇷 FR Taxable | 30% | 46.67% | 43.87% | $4,667 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 HLTRF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 HLTRF Dividend Payment Schedule
HLTRF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 HLTRF vs Healthcare Benchmarks
How HLTRF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HLTRF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ HLTRF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HLTRF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
HLS Therapeutics Inc. (HLTRF) is currently trading at $3.00, 81% below its 52-week high. The current dividend yield is 66.67% based on an annual payout of $2.00 per share.
HLTRF (HLS Therapeutics Inc.) — 66.67% Dividend Yield Analysis
HLS Therapeutics Inc. (HLTRF) is a healthcare stock currently trading at $3.00 with a dividend yield of 66.67%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, HLTRF has grown its dividend at a compound annual rate of 50.0%.
- Above-average yield (66.67%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.